PRESS RELEASE published on 09/18/2024 at 12:05, 2 months 4 days ago Rapport semestriel au 30 juin 2024
BRIEF published on 09/16/2024 at 11:22, 2 months 6 days ago La Banque Palatine introduit Palatine Avenir 2030, un titre de créance à risque Investissement Marché Actions Banque Palatine Titre De Créance Risque De Capital
BRIEF published on 09/16/2024 at 11:22, 2 months 6 days ago Banque Palatine introduces Palatine Avenir 2030, a risky debt security Investment Stock Market Palatine Bank Debt Security Capital Risk
PRESS RELEASE published on 09/16/2024 at 11:17, 2 months 6 days ago Informations privilégiées / Autres communiqués La Banque Palatine lance Palatine Avenir 2030, un titre de créance à risque. Détails financiers et modalités de souscription inclus Souscription Banque Palatine Titre De Créance Palatine Avenir 2030 Risque
BRIEF published on 09/12/2024 at 10:50, 2 months 10 days ago Availability of the Final Terms of the 579 series issue tranche 1 by BFCM Investors Final Terms Crédit Mutuel BFCM Series 579 Broadcast
BRIEF published on 09/12/2024 at 10:50, 2 months 10 days ago Disponibilité des Final Terms de l'émission série 579 tranche 1 par la BFCM Investisseurs Final Terms Crédit Mutuel BFCM Émission Série 579
PRESS RELEASE published on 09/12/2024 at 10:45, 2 months 10 days ago BFCM Communiqué de mise à disposition des Final Terms de l’émission série 579 tranche 1 La Banque Fédérative du Crédit Mutuel communique les modalités de disponibilité des Final Terms de l’émission séries 579 tranche 1. Les documents sont accessibles sur le site de l’émetteur Final Terms Modalités Émission Document BFCM
BRIEF published on 09/12/2024 at 08:42, 2 months 10 days ago Sanofi, RadioMedix et Orano Med annoncent un accord de licence exclusif pour la thérapie par radioligand Sanofi Orano Med AlphaMedix Radio Médix Tumeurs Neuroendocrines
BRIEF published on 09/12/2024 at 08:42, 2 months 10 days ago Sanofi, RadioMedix, and Orano Med Announce Exclusive Licensing Agreement for Radioligand Therapy Sanofi RadioMedix Orano Med AlphaMedix Neuroendocrine Tumors
Published on 11/22/2024 at 23:55, 6 hours 48 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 7 hours 13 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 7 hours 38 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 8 hours 13 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 12 hours 28 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 12 hours 49 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 13 hours 47 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 14 hours 43 minutes ago Proposed cancellation of admission to trading
Published on 11/22/2024 at 16:15, 14 hours 27 minutes ago NRJ GROUP - Le Conseil d'Etat rejette le recours de NRJ 12 et NRJ GROUP
Published on 11/21/2024 at 06:58, 1 day 23 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
